BRIEF-U.S. Federal Register FDA Announcing Revocation Of Euas Issued To Bio-Rad Laboratories

Reuters05-17

May 17 (Reuters) - Bio Rad Laboratories Inc :

* U.S. FEDERAL REGISTER: FDA ANNOUNCING REVOCATION OF EUAS ISSUED TO BIO-RAD LABORATORIES FOR THE BIO-RAD SARS-COV-2 DDPCR KIT

* U.S. FEDERAL REGISTER: FDA ANNOUNCING REVOCATION OF EUAS ISSUED TO FAST TRACK DIAGNOSTICS LUXEMBOURG S.Á.R.L. FOR FTD SARS-COV-2

* U.S. FEDERAL REGISTER: FDA REVOKED AUTHORIZATIONS UNDER FEDERAL FOOD, DRUG, AND COSMETIC ACT AS REQUESTED BY THE AUTHORIZATION HOLDERS

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2436990951?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-05-17 19:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2436990951","market":"us","top_or_hot":-1,"title":"BRIEF-U.S. Federal Register FDA Announcing Revocation Of Euas Issued To Bio-Rad Laboratories","media":"Reuters","content":"<html><body><p>May 17 (Reuters) - Bio Rad Laboratories Inc   :</p><p>   * U.S. FEDERAL REGISTER: FDA ANNOUNCING REVOCATION OF EUAS ISSUED TO BIO-RAD LABORATORIES FOR THE BIO-RAD SARS-COV-2 DDPCR KIT</p><p>   * U.S. FEDERAL REGISTER: FDA ANNOUNCING REVOCATION OF EUAS ISSUED TO FAST TRACK DIAGNOSTICS LUXEMBOURG S.Á.R.L. FOR FTD SARS-COV-2</p><p>   * U.S. FEDERAL REGISTER: FDA REVOKED AUTHORIZATIONS UNDER FEDERAL FOOD, DRUG, AND COSMETIC ACT AS REQUESTED BY THE AUTHORIZATION HOLDERS</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-U.S. Federal Register FDA Announcing Revocation Of Euas Issued To Bio-Rad Laboratories</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-U.S. Federal Register FDA Announcing Revocation Of Euas Issued To Bio-Rad Laboratories\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-17 19:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>May 17 (Reuters) - Bio Rad Laboratories Inc   :   * U.S. FEDERAL REGISTER: FDA ANNOUNCING REVOCATION OF EUAS ISSUED TO BIO-RAD LABORATORIES FOR THE BIO-RAD SARS-COV-2 DDPCR KIT   * U.S. FEDERAL ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2436990951","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2436990951","pubTimestamp":1715944962,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"May 17  - Bio Rad Laboratories Inc   :   * U.S. FEDERAL REGISTER: FDA ANNOUNCING REVOCATION OF EUAS ISSUED TO BIO-RAD LABORATORIES FOR THE BIO-RAD SARS-COV-2 DDPCR KIT   * U.S. FEDERAL REGISTER: FDA ANNOUNCING REVOCATION OF EUAS ISSUED TO FAST TRACK DIAGNOSTICS LUXEMBOURG S..R.L. FOR FTD SARS-COV-2   * U.S. FEDERAL REGISTER: FDA REVOKED AUTHORIZATIONS UNDER FEDERAL FOOD, DRUG, AND COSMETIC ACT AS REQUESTED BY THE AUTHORIZATION HOLDERSSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4121":"生命科学工具和服务","BIO":"Bio Rad实验室","BK4588":"碎股","BIO.B":"Bio-Rad Laboratories Inc Cl B","FAST":"快扣","BK4567":"ESG概念","BK4104":"贸易公司与经销商","BK4585":"ETF&股票定投概念"},"translate_title":"简介——美国联邦注册FDA宣布撤销发给Bio-Rad实验室的Euas","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIO.B":1,"BIO":0.9,"FAST":0.75},"content_text":"May 17 (Reuters) - Bio Rad Laboratories Inc   :   * U.S. FEDERAL REGISTER: FDA ANNOUNCING REVOCATION OF EUAS ISSUED TO BIO-RAD LABORATORIES FOR THE BIO-RAD SARS-COV-2 DDPCR KIT   * U.S. FEDERAL REGISTER: FDA ANNOUNCING REVOCATION OF EUAS ISSUED TO FAST TRACK DIAGNOSTICS LUXEMBOURG S.Á.R.L. FOR FTD SARS-COV-2   * U.S. FEDERAL REGISTER: FDA REVOKED AUTHORIZATIONS UNDER FEDERAL FOOD, DRUG, AND COSMETIC ACT AS REQUESTED BY THE AUTHORIZATION HOLDERSSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2436990951"}